2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$217.51+$1.39 (+0.64%)
Price as of Jul 06, 2026 4:10 AM EDT- $31.9BMarket Cap
- 62.66%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$217.51+$1.39 (+0.64%)
Earnings Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 0.67% | ||
12-Month Momentum | 41.77% | ||
3-Month Risk Adjusted Momentum | 4.61% | ||
12-Month Risk Adjusted Momentum | 129.47% |
True Yield
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.008% |
Financial Health Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 8 |